We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

221 hedge funds and large institutions have $1.74B invested in Adaptive Biotechnologies in 2022 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 88 increasing their positions, 48 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 48

26% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 39

3% more funds holding

Funds holding: 214 → 221 (+7)

1.23% more ownership

Funds ownership: 87.48% → 88.71% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

43% less call options, than puts

Call options by funds: $1.19M | Put options by funds: $2.09M

50% less capital invested

Capital invested by funds: $3.46B → $1.74B (-$1.72B)

Holders
221
Holders Change
+7
Holders Change %
+3.27%
% of All Funds
3.49%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
49
Increased
88
Reduced
48
Closed
39
Calls
$1.19M
Puts
$2.09M
Net Calls
-$904K
Net Calls Change
-$6.13M

Top Buyers

1
AIM
ARK Investment Management
Florida
+$31.6M
2
BG
Bellevue Group
Switzerland
+$18.5M
3
NAMA
Nikko Asset Management Americas
New York
+$15.4M
4
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$14.7M
5
Marshall Wace
Marshall Wace
United Kingdom
+$13.3M

Top Sellers

1
Capital International Investors
Capital International Investors
California
-$58.8M
2
GGHC
Gilder Gagnon Howe & Co
New York
-$26.5M
3
Invesco
Invesco
Georgia
-$22.1M
4
ZCI
Zevenbergen Capital Investments
Washington
-$19.6M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$17.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$8.19M +$6.9M +438,640 +290%
TM
27
Tiger Management
New York
$8.18M -$8.27M -526,100 -47%
Federated Hermes
28
Federated Hermes
Pennsylvania
$7.72M +$8.74M +556,199 New
Principal Financial Group
29
Principal Financial Group
Iowa
$7.16M +$536K +34,064 +7%
Morgan Stanley
30
Morgan Stanley
New York
$7.04M +$1.82M +115,575 +30%
PPA
31
Parametric Portfolio Associates
Washington
$6.46M +$6.37M +405,466 +675%
Northern Trust
32
Northern Trust
Illinois
$6.44M -$33.8K -2,149 -0.5%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$6.42M -$182K -11,584 -2%
Renaissance Technologies
34
Renaissance Technologies
New York
$6.32M +$7.16M +455,600 New
Allianz Asset Management
35
Allianz Asset Management
Germany
$5.08M -$554K -35,215 -9%
Deutsche Bank
36
Deutsche Bank
Germany
$4.74M +$3.25M +206,421 +153%
PC
37
Pier Capital
Connecticut
$4.71M +$2.25M +143,239 +73%
TCM
38
Tekla Capital Management
Massachusetts
$4.69M – – –
JP Morgan Chase
39
JP Morgan Chase
New York
$4.57M +$777K +49,451 +18%
PCM
40
Peregrine Capital Management
Minnesota
$4.42M -$335K -21,316 -6%
CSS
41
Cubist Systematic Strategies
Connecticut
$4.3M +$3.48M +221,235 +250%
TM
42
Triatomic Management
California
$4.12M +$3.59M +228,108 +331%
N
43
Nuveen
North Carolina
$4.11M +$348K +22,124 +7%
Thrivent Financial for Lutherans
44
Thrivent Financial for Lutherans
Minnesota
$4.07M -$4.64M -294,814 -50%
Carson Wealth (CWM LLC)
45
Carson Wealth (CWM LLC)
Nebraska
$3.74M -$545K -34,694 -11%
DC
46
Diametric Capital
Massachusetts
$3.68M +$4.17M +265,000 New
Lazard Asset Management
47
Lazard Asset Management
New York
$3.29M -$15.8M -1,004,636 -81%
Jane Street
48
Jane Street
New York
$3.18M +$3.31M +210,530 +1,147%
Swiss National Bank
49
Swiss National Bank
Switzerland
$3.01M +$241K +15,300 +8%
Bank of America
50
Bank of America
North Carolina
$2.91M -$368K -23,413 -10%
1
2
3 4 5

ADPT Hedge Fund Activity: Q1 2022 in Review

221 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q1 2022, worth a combined $1.74B — down 50% from $3.46B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new ADPT positions and 39 closed out — a net gain of 10 holders — while 88 added to existing stakes and 48 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $31.6M. The largest seller was Capital International Investors, exiting entirely with an estimated $58.8M sold.

  • 221 institutional investors held Adaptive Biotechnologies (ADPT) as of Q1 2022, up from 214 in Q4 2021.
  • Funds reported $1.74B of Adaptive Biotechnologies stock for Q1 2022, down 50% quarter-over-quarter.
  • 49 funds opened new Adaptive Biotechnologies positions in Q1 2022 and 39 closed out, a net change of +10 holders.
  • The largest Adaptive Biotechnologies buyer in Q1 2022 was ARK Investment Management, an estimated $31.6M added.
  • The largest Adaptive Biotechnologies seller in Q1 2022 was Capital International Investors, an estimated $58.8M sold.

Based on aggregated 13F filings for Q1 2022.